BBIO - BridgeBio Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BBIO is currently covered by 13 analysts with an average price target of $74.15. This is a potential upside of $19.36 (35.33%) from yesterday's end of day stock price of $54.79.

BridgeBio Pharma's activity chart (see below) currently has 166 price targets and 144 ratings on display. The stock rating distribution of BBIO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.73% with an average time for these price targets to be met of 272.88 days.

Highest price target for BBIO is $95, Lowest price target is $46, average price target is $64.23.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 14-Sep-2025. First documented stock forecast 21-Jul-2019.

Currently out of the existing stock ratings of BBIO, 36 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$70

$17.14 (32.43%)

$70

25 days ago
(14-Sep-2025)

22/29 (75.86%)

$18.53 (36.00%)

309

Buy

$82

$29.14 (55.13%)

$72

28 days ago
(11-Sep-2025)

4/8 (50%)

$30.79 (60.12%)

342

Buy

$70

$17.14 (32.43%)

$50

1 months 7 days ago
(02-Sep-2025)

13/15 (86.67%)

$18.16 (35.03%)

176

Buy

$61

$8.14 (15.40%)

$60

2 months 4 days ago
(05-Aug-2025)

0/2 (0%)

$16.19 (36.13%)

Buy

$57

$4.14 (7.83%)

$55

2 months 4 days ago
(05-Aug-2025)

8/10 (80%)

$12.19 (27.20%)

219

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BBIO (BridgeBio Pharma) average time for price targets to be met?

On average it took 272.88 days on average for the stock forecasts to be realized with a an average price target met ratio 69.73

Which analyst has the current highest performing score on BBIO (BridgeBio Pharma) with a proven track record?

CORY KASIMOV

Which analyst has the most public recommendations on BBIO (BridgeBio Pharma)?

Cory Kasimov works at EVERCORE and has 8 price targets and 6 ratings on BBIO

Which analyst is the currently most bullish on BBIO (BridgeBio Pharma)?

Josh Schimmer with highest potential upside - $42.14

Which analyst is the currently most reserved on BBIO (BridgeBio Pharma)?

Eun Yang with lowest potential downside - -$28.86

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?